Q4 2024 Earnings Estimate for Ashland Inc. (NYSE:ASH) Issued By Seaport Res Ptn

Ashland Inc. (NYSE:ASH) – Analysts at Seaport Res Ptn upped their Q4 2024 earnings per share (EPS) estimates for shares of Ashland in a note issued to investors on Monday, May 6th. Seaport Res Ptn analyst M. Harrison now anticipates that the basic materials company will earn $1.57 per share for the quarter, up from their previous estimate of $1.55. The consensus estimate for Ashland’s current full-year earnings is $4.47 per share. Seaport Res Ptn also issued estimates for Ashland’s FY2025 earnings at $6.00 EPS.

A number of other analysts also recently issued reports on the company. Mizuho raised their target price on Ashland from $101.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. BMO Capital Markets raised their target price on Ashland from $97.00 to $105.00 and gave the stock a “market perform” rating in a research note on Tuesday. TheStreet raised Ashland from a “c+” rating to a “b-” rating in a research note on Thursday, February 22nd. Jefferies Financial Group upgraded shares of Ashland from a “hold” rating to a “buy” rating and lifted their price target for the company from $100.00 to $126.00 in a research report on Thursday, March 14th. Finally, Wolfe Research initiated coverage on shares of Ashland in a report on Friday, March 1st. They issued an “outperform” rating and a $108.00 target price for the company. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $106.44.

Ashland Trading Up 0.7 %

Shares of Ashland stock opened at $98.02 on Tuesday. Ashland has a 1-year low of $70.82 and a 1-year high of $99.55. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.15 and a quick ratio of 1.94. The stock has a market cap of $4.91 billion, a P/E ratio of 26.00 and a beta of 0.92. The stock’s 50 day simple moving average is $95.80 and its 200-day simple moving average is $87.29.

Ashland (NYSE:ASH) last issued its earnings results on Wednesday, May 1st. The basic materials company reported $1.27 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.13. The business had revenue of $575.00 million during the quarter, compared to analysts’ expectations of $574.64 million. Ashland had a net margin of 9.09% and a return on equity of 5.57%. The company’s quarterly revenue was down 4.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.43 earnings per share.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. GAMMA Investing LLC increased its stake in shares of Ashland by 122.4% during the first quarter. GAMMA Investing LLC now owns 278 shares of the basic materials company’s stock worth $27,000 after buying an additional 153 shares during the period. Global Retirement Partners LLC acquired a new stake in Ashland during the fourth quarter worth approximately $28,000. Hexagon Capital Partners LLC lifted its position in shares of Ashland by 143.9% during the 4th quarter. Hexagon Capital Partners LLC now owns 378 shares of the basic materials company’s stock worth $32,000 after buying an additional 223 shares during the last quarter. Covestor Ltd boosted its stake in Ashland by 338.0% in the third quarter. Covestor Ltd now owns 403 shares of the basic materials company’s stock valued at $33,000 after acquiring an additional 311 shares in the last quarter. Finally, Allworth Financial LP boosted its position in shares of Ashland by 43.1% in the 3rd quarter. Allworth Financial LP now owns 561 shares of the basic materials company’s stock valued at $46,000 after purchasing an additional 169 shares during the period. 93.95% of the stock is currently owned by hedge funds and other institutional investors.

About Ashland

Ashland Inc provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.